We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stimulation Probe Identifies and Protects Cranial Nerves

By HospiMedica International staff writers
Posted on 13 Aug 2008
An infrared neural stimulation (INS) device that identifies nerves could help people with hearing injuries and aid surgeons in ear, nose, and throat (ENT) procedures.

An award granted by the U.S. More...
National Institutes of Health (NIH, Bethesda, MD, USA) is intended to help fund the development of a handheld laser-based nerve stimulator for use by ENT specialists to identify cranial nerves during surgery. The planned device will use INS, a versatile technology that is also poised to diagnose and treat those suffering neurological trauma, including the growing population of young, brain-injured U.S. veterans returning from combat. The design goal is a compact probe that gives surgeons precise, real-time feedback on cranial nerve function during the surgical procedure. By precisely locating critical nerves, the risk of inadvertent damage and subsequent functional loss could be significantly reduced. INS promises improved spatial resolution and scanning ability, allowing superior tumor resection and surgical outcomes. Potential uses include identifying the facial nerves during head and neck surgery, substantially lowering the risk of facial paralysis, which can occur in extreme cases. The INS device will be developed by Aculight (Bothell, WA, USA), under the U.S. federal small business innovation research (SBIR) program.

"Aculight's INS technology is particularly important now because of the need for cutting-edge treatments for the hearing impaired and injured, such as many of the men and women returning from combat in the Iraq and Afghanistan theaters,” said Mark Bendett, Aculight director of medical products. "In these environments our veterans have been exposed to conditions such as IED [improvised explosive device] blasts, which cause brain injuries, hearing loss, limb amputation, and other deficits that could benefit from the technology we are developing.”

Related Links:
U.S. National Institutes of Health
Aculight


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.